Recurrent monomorphic epitheliotropic intestinal T-cell lymphoma with aberrant CD20 expression: An implication for anti-CD20 (rituximab) antibody therapy?

Pathol Int. 2018 Dec;68(12):712-714. doi: 10.1111/pin.12730. Epub 2018 Nov 6.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antigens, CD20 / biosynthesis*
  • Antineoplastic Agents, Immunological / therapeutic use*
  • Biomarkers, Tumor / analysis
  • Enteropathy-Associated T-Cell Lymphoma / drug therapy
  • Enteropathy-Associated T-Cell Lymphoma / metabolism
  • Enteropathy-Associated T-Cell Lymphoma / pathology*
  • Fatal Outcome
  • Female
  • Humans
  • Neoplasm Recurrence, Local / drug therapy
  • Neoplasm Recurrence, Local / metabolism
  • Neoplasm Recurrence, Local / pathology*
  • Rituximab / therapeutic use*

Substances

  • Antigens, CD20
  • Antineoplastic Agents, Immunological
  • Biomarkers, Tumor
  • Rituximab